ClinicalTrials.Veeva

Menu

Efficiency of Speech and Language Intervention on Achievement of Children With Developmental Language Disorder (DYSPHADEV)

C

Centre Hospitalier Universitaire, Amiens

Status

Completed

Conditions

Therapy
Speech and Language Disorder
Language Development Disorders

Study type

Observational

Funder types

Other

Identifiers

NCT04926311
PI2018_843_0052

Details and patient eligibility

About

Children with Developmental Language Disorder (DLD) have many linguistic difficulties in syntax, lexicon, morphology and phonology. Frequently, they also present co-occurrent (or comorbidities) impairments which further impaired school learning. Thus, they have poor academic outcomes and many of these children have been maintained at least one time in a classroom, sometime more.

The purpose of this project is to determine which modalities of speech and language therapy are the more efficient on academic outcomes of children with DLD. The main modalities that will be studied are the duration of speech and language intervention, the age at which begins the intervention and the intensity (number of intervention sessions per week).

Enrollment

130 patients

Sex

All

Ages

12+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients Have been diagnosed in the University Hospital of Amiens-Picardie with a Developmental Language Disorder
  • patients must be aged 12 or older,
  • patients must be agreed answering the questionnaire

Exclusion criteria

  • Children with a neurological pathology or handicap as epilepsy, cerebral palsy, sequelae of severe brain injury (traumatic or ischemic or inflammatory...)
  • patients with a severe mental retardation
  • patients with autism
  • patients with bipolar illness
  • patients with psychosis

Trial design

130 participants in 1 patient group

Developmental Language Disorder patients

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems